title: Ovarian cancer in younger vs older women: a population-based analysis.
abstract: To compare the clinico-pathologic prognostic factors and survival of younger vs older women diagnosed with epithelial ovarian cancer. Demographic, clinico-pathologic, treatment, and surgery information were obtained from patients with ovarian cancer from the Surveillance, Epidemiology, and End Results Program from 1988 to 2001 and analysed using Kaplan-Meier estimates. Of 28 165 patients, 400 were <30 years (very young), 11 601 were 30-60 (young), and 16 164 were >60 (older) years of age. Of the very young, young, and older patients, 261 (65.3%), 4664 (40.2%), and 3643 (22.5%) had stage I-II disease, respectively (P<0.001). Across all stages, very young women had a significant survival advantage over the young and older groups with 5-year disease-specific survival estimates at 78.8% vs 58.8 and 35.3%, respectively (P<0.001). This survival difference between the age groups persists even after adjusting for race, stage, grade, and surgical treatment. Reproductive age (16-40 years) women with stage I-II epithelial ovarian cancer who received uterine-sparing procedures had similar survivals compared to those who underwent standard surgery (93.3% vs 91.5%, P=0.26). Younger women with epithelial ovarian cancer have a survival advantage compared to older patients.
authors.affiliation: Division of Gynecologic Oncology, Stanford, CA 94305, USA. johnchan@stanford.edu
authors.forename: J K
authors.initials: JK
authors.lastname: Chan
authors.forename: R
authors.initials: R
authors.lastname: Urban
authors.forename: M K
authors.initials: MK
authors.lastname: Cheung
authors.forename: K
authors.initials: K
authors.lastname: Osann
authors.forename: J Y
authors.initials: JY
authors.lastname: Shin
authors.forename: A
authors.initials: A
authors.lastname: Husain
authors.forename: N N
authors.initials: NN
authors.lastname: Teng
authors.forename: D S
authors.initials: DS
authors.lastname: Kapp
authors.forename: J S
authors.initials: JS
authors.lastname: Berek
authors.forename: G S
authors.initials: GS
authors.lastname: Leiserowitz
mesh_terms: D018262:Adenocarcinoma, Clear Cell / Q000453:epidemiology* / Q000401:mortality / Q000601:surgery; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008875:Middle Aged; D009375:Neoplasms, Glandular and Epithelial / Q000453:epidemiology* / Q000401:mortality / Q000601:surgery; D010051:Ovarian Neoplasms / Q000453:epidemiology* / Q000401:mortality / Q000601:surgery; D011379:Prognosis; D018426:SEER Program; D015996:Survival Rate; D014481:United States / Q000453:epidemiology